Evidence map›Paper›PMID 39384938›Full record

ArticleScientific reports2024

Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data.

Alireza Farnoush, Zahra Sedighi-Maman, Behnam Rasoolian, Jonathan J Heath, Banafsheh Fallah

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Alireza FarnoushDarla Moore School of Business, University of South Carolina, Columbia, SC, 29208, USA. alireza.farnoush@moore.sc.edu.
Zahra Sedighi-MamanRobert B. Willumstad School of Business, Adelphi University, Garden City, NY, 11530, USA.
Behnam RasoolianDepartment of Industrial and System Engineering, Auburn University, Auburn, AL, 36849, USA.
Jonathan J HeathSchool of Business, St. Bonaventure University, St Bonaventure, Washington, NY, 14778, USA.
Banafsheh FallahDepartment of Industrial and System Engineering, Auburn University, Auburn, AL, 36849, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of adverse drug reactions (ADRs) is an ongoing public health concern. While traditional methods to discover ADRs are very costly and limited, it is prudent to predict ADRs through non-invasive methods such as machine learning based on existing data. Although various studies exist regarding ADR prediction using non-clinical data, a process that leverages both demographic and non-clinical data for ADR prediction is missing. In addition, the importance of individual features in ADR prediction has yet to be fully explored. This study aims to develop an ADR prediction model based on demographic and non-clinical data, where we identify the highest contributing factors. We focus our efforts on 30 common and severe ADRs reported to the Food and Drug Administration (FDA) between 2012 and 2023. We have developed a random forest (RF) and deep learning (DL) machine learning model that ingests demographic data (e.g., Age and Gender of patients) and non-clinical data, which includes chemical, molecular, and biological drug characteristics. We successfully unified both demographic and non-clinical data sources within a complete dataset regarding ADR prediction. Model performances were assessed via the area under the receiver operating characteristic curve (AUC) and the mean average precision (MAP). We demonstrated that our parsimonious models, which include only the top 20 most important features comprising 5 demographic features and 15 non-clinical features (13 molecular and 2 biological), achieve ADR prediction performance comparable to a less practical, feature-rich model consisting of all 2,315 features. Specifically, our models achieved an AUC of 0.611 and 0.674 for RF and DL algorithms, respectively. We hope our research provides researchers and clinicians with valuable insights and facilitates future research designs by identifying top ADR predictors (including demographic information) and practical parsimonious models.

Indexed as

Drug-Related Side Effects and Adverse ReactionsMachine LearningAdolescentAdultAdverse Drug Reaction Reporting SystemsAgedChildDeep LearningFemaleHumansMaleMiddle AgedUnited StatesUnited States Food and Drug AdministrationYoung AdultAdverse drug reactionsDeep learningDemographic featuresMachine learningNon-clinical featuresRandom forest

Identifiers

PMID39384938
PMCPMC11464664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.